Arctic Aurora LifeScience is managed by a highly experienced and complementary team with a broad successful track record in equity asset management, pharmaceutical product development and commercialization, financing, M&A and risk management.
The team has deep knowledge and coverage of both the US and Europe Life Science market with a unique network within pharma, biotech, life science and the investment community. Their long standing relationship with management teams and industry thought leaders provides unparalleled awareness of opportunities.
Sales and Product Specialist
For general enquiries and information on how to invest in Arctic Aurora Life Science, please send an e-mail to firstname.lastname@example.org or contact Sales and Product Specialist:
Vegard Gjølme - Norway / Int'l
Anna Jakobsen - Sweden
Spring Green Capital
Phone: + 46 8 72 050 90 24
Visting address Stocholm
Visiting address Stockholm is Regeringsgatan 38, Stockholm
A group consisting of highly senior executives from the pharmaceutical, biotechnology and banking sector acts as a sounding board to the portfolio management team on specific topics regarding scientific advice during due diligence and identification of investment ideas on particular therapeutic areas and upcoming technologies, strategic advice and deal access.
- Invest in Arctic Aurora LifeScience - Private Clients (Norwegian only)
- For institutional clients, please contact one of our product specialist
Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish AP3 Fonder, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both hedged and un-hedged share classes.
Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.